• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MyD88 衔接蛋白在阿尔茨海默病小鼠模型中作为预防记忆缺陷的机制。

MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease.

机构信息

Laboratory of Endocrinology and Genomics, CHUL Research Center and Department of Molecular Medicine, Faculty of Medicine, Laval University, 2705 Laurier boul,, Québec, G1V 4G2, Canada.

出版信息

Mol Neurodegener. 2011 Jan 14;6(1):5. doi: 10.1186/1750-1326-6-5.

DOI:10.1186/1750-1326-6-5
PMID:21235801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3030527/
Abstract

BACKGROUND

Alzheimer's disease (AD) is an age-related neurodegenerative disorder associated with brain innate immune activation mainly mediated by microglia. These cells are known to be activated in the brain of AD patients and to produce inflammatory cytokines and neurotoxic molecules in response to Amyloid beta (Aβ). Activation of microglia can also promote Aβ clearance via Toll-like receptors (TLRs). Myeloid differentiation factor 88 (MyD88) is the adaptor molecule for most of these innate immune receptors, transducing the intracellular signal from TLRs to nucleus.

RESULTS

Here, we report that more than 50% reduction in MyD88 expression in a mouse model of AD accelerated spatial learning and memory deficits. Brain of APPswe/PS1-MyD88+/- mice was characterized by a delay in accumulation of Aβ plaques and increased soluble levels of Aβ oligomers. Furthermore, inflammatory monocyte subset and brain IL-1β gene expression were significantly reduced in APPswe/PS1 mice with impaired MyD88 signaling.

CONCLUSIONS

These data indicate that activation of MyD88 intracellular signaling pathway, likely by TLRs, acts as a natural innate immune mechanism to restrict disease progression of APPswe/PS1 mice.

摘要

背景

阿尔茨海默病(AD)是一种与年龄相关的神经退行性疾病,与大脑固有免疫激活有关,主要由小胶质细胞介导。这些细胞已知在 AD 患者的大脑中被激活,并在响应淀粉样蛋白β(Aβ)时产生炎症细胞因子和神经毒性分子。小胶质细胞的激活还可以通过 Toll 样受体(TLR)促进 Aβ清除。髓样分化因子 88(MyD88)是这些固有免疫受体的大多数衔接分子,将 TLR 从细胞内信号转导到细胞核。

结果

在这里,我们报告说,AD 小鼠模型中 MyD88 表达减少超过 50%,加速了空间学习和记忆缺陷。APPswe/PS1-MyD88+/- 小鼠的大脑表现为 Aβ 斑块积累延迟和可溶性 Aβ 寡聚物水平增加。此外,APPswe/PS1 小鼠中 MyD88 信号受损时,炎症单核细胞亚群和脑 IL-1β 基因表达显著降低。

结论

这些数据表明,MyD88 细胞内信号通路的激活,可能通过 TLRs,作为一种天然的固有免疫机制,限制 APPswe/PS1 小鼠的疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/8b1f674ebd0e/1750-1326-6-5-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/9b4ee97a8065/1750-1326-6-5-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/70a6ca6686af/1750-1326-6-5-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/6e41a9e08b96/1750-1326-6-5-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/55ac481a28a8/1750-1326-6-5-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/8b1f674ebd0e/1750-1326-6-5-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/9b4ee97a8065/1750-1326-6-5-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/70a6ca6686af/1750-1326-6-5-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/6e41a9e08b96/1750-1326-6-5-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/55ac481a28a8/1750-1326-6-5-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31e/3030527/8b1f674ebd0e/1750-1326-6-5-5.jpg

相似文献

1
MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease.MyD88 衔接蛋白在阿尔茨海默病小鼠模型中作为预防记忆缺陷的机制。
Mol Neurodegener. 2011 Jan 14;6(1):5. doi: 10.1186/1750-1326-6-5.
2
MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease.MyD88 缺乏症可改善阿尔茨海默病动物模型中的β-淀粉样蛋白沉积。
Am J Pathol. 2011 Sep;179(3):1095-103. doi: 10.1016/j.ajpath.2011.05.045. Epub 2011 Jul 19.
3
Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's disease.髓系分化因子 88 衔接蛋白在阿尔茨海默病认知缺陷中作为一种天然防御机制。
Stem Cell Rev Rep. 2012 Sep;8(3):898-904. doi: 10.1007/s12015-012-9356-9.
4
MyD88 acts as an adaptor protein for inflammatory signalling induced by amyloid-β in macrophages.髓样分化因子88(MyD88)作为巨噬细胞中由β-淀粉样蛋白诱导的炎症信号传导的衔接蛋白。
Immunol Lett. 2014 Nov;162(1 Pt A):109-18. doi: 10.1016/j.imlet.2014.08.001. Epub 2014 Aug 12.
5
Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence.早期小刺激微胶质细胞 TLR2 和 TLR4 受体可减轻大鼠阿尔茨海默病相关认知缺陷:行为、分子和电生理证据。
Neurobiol Aging. 2018 Oct;70:203-216. doi: 10.1016/j.neurobiolaging.2018.06.020. Epub 2018 Jun 28.
6
Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.在阿尔茨海默病转基因小鼠模型中,Toll样受体4依赖性细胞因子上调
J Neuroinflammation. 2008 May 29;5:23. doi: 10.1186/1742-2094-5-23.
7
Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.法舒地尔对 APP/PS1 转基因小鼠的多靶点治疗作用。
CNS Neurol Disord Drug Targets. 2017;16(2):199-209. doi: 10.2174/1871527315666160711104719.
8
Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.在衰老过程中,野生型小鼠小胶质细胞对脂多糖的反应增强,但在阿尔茨海默病小鼠模型中则减弱:Toll样受体4信号在疾病进展中的意义。
Biochem Biophys Res Commun. 2016 Oct 14;479(2):331-337. doi: 10.1016/j.bbrc.2016.09.073. Epub 2016 Sep 15.
9
Reduced photoreceptor death and improved retinal function during retinal degeneration in mice lacking innate immunity adaptor protein MyD88.在缺乏先天性免疫衔接蛋白MyD88的小鼠视网膜变性过程中,光感受器死亡减少,视网膜功能改善。
Exp Neurol. 2015 May;267:1-12. doi: 10.1016/j.expneurol.2015.02.027. Epub 2015 Feb 25.
10
Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia.淀粉样β蛋白(1-42)原纤维刺激了一定量分泌型白细胞介素-1β,尽管小胶质细胞内有大量白细胞介素-1β积累。
Biochim Biophys Acta. 2014 Nov;1842(11):2276-85. doi: 10.1016/j.bbadis.2014.08.001. Epub 2014 Aug 11.

引用本文的文献

1
Early ultrasonic vocalization deficits and related thyroarytenoid muscle pathology in the transgenic TgF344-AD rat model of Alzheimer's disease.阿尔茨海默病转基因TgF344-AD大鼠模型中的早期超声发声缺陷及相关的甲杓肌病理变化
Front Behav Neurosci. 2024 Jan 23;17:1294648. doi: 10.3389/fnbeh.2023.1294648. eCollection 2023.
2
Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer's disease?动力相关蛋白1(Drp1)是阿尔茨海默病中线粒体功能障碍与炎症之间的联系吗?
Front Mol Neurosci. 2023 May 12;16:1166879. doi: 10.3389/fnmol.2023.1166879. eCollection 2023.
3
Deletion of MyD88 in astrocytes prevents β-amyloid-induced neuropathology in mice.

本文引用的文献

1
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.模式识别受体在天然免疫中的作用:Toll 样受体更新。
Nat Immunol. 2010 May;11(5):373-84. doi: 10.1038/ni.1863. Epub 2010 Apr 20.
2
Toll-like receptor 2-independent and MyD88-dependent gene expression in the mouse brain.在小鼠大脑中 Toll 样受体 2 非依赖性和 MyD88 依赖性基因表达。
J Innate Immun. 2009;1(5):480-93. doi: 10.1159/000225990. Epub 2009 Jun 20.
3
Abeta promotes Alzheimer's disease-like cytoskeleton abnormalities with consequences to APP processing in neurons.
星形胶质细胞中 MyD88 的缺失可防止小鼠β-淀粉样蛋白诱导的神经病理学。
Glia. 2023 Feb;71(2):431-449. doi: 10.1002/glia.24285. Epub 2022 Oct 22.
4
Microglia in Alzheimer's Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis.阿尔茨海默病中的小胶质细胞:在稳态与发病机制转变中的关键角色。
Neurotherapeutics. 2022 Jan;19(1):186-208. doi: 10.1007/s13311-021-01179-3. Epub 2022 Mar 14.
5
Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders.用于神经炎症介导的神经退行性疾病的小分子疗法。
RSC Med Chem. 2021 Apr 13;12(6):871-886. doi: 10.1039/d1md00036e. eCollection 2021 Jun 23.
6
Transcriptional signature in microglia associated with Aβ plaque phagocytosis.与 Aβ 斑块吞噬作用相关的小胶质细胞转录特征。
Nat Commun. 2021 May 21;12(1):3015. doi: 10.1038/s41467-021-23111-1.
7
Targeting innate immunity to protect and cure Alzheimer's disease: opportunities and pitfalls.靶向固有免疫以保护和治疗阿尔茨海默病:机遇与陷阱。
Mol Psychiatry. 2021 Oct;26(10):5504-5515. doi: 10.1038/s41380-021-01083-4. Epub 2021 Apr 14.
8
Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models.高血糖引起的神经炎症损害血脑屏障,导致 1 型和 2 型糖尿病小鼠模型的记忆丧失。
Mol Neurobiol. 2019 Mar;56(3):1883-1896. doi: 10.1007/s12035-018-1195-5. Epub 2018 Jul 5.
9
Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.I 型干扰素通路在神经炎症和神经退行性变中的作用:聚焦于阿尔茨海默病。
J Neural Transm (Vienna). 2018 May;125(5):797-807. doi: 10.1007/s00702-017-1745-4. Epub 2017 Jul 4.
10
Inflammasomes as therapeutic targets for Alzheimer's disease.炎症小体作为阿尔茨海默病的治疗靶点。
Brain Pathol. 2017 Mar;27(2):223-234. doi: 10.1111/bpa.12478.
Abeta 促进了阿尔茨海默病样细胞骨架异常,导致神经元中 APP 的加工受到影响。
J Neurochem. 2010 May;113(3):761-71. doi: 10.1111/j.1471-4159.2010.06643.x. Epub 2010 Mar 23.
4
Fibril fragmentation enhances amyloid cytotoxicity.原纤维片段化增强淀粉样蛋白的细胞毒性。
J Biol Chem. 2009 Dec 4;284(49):34272-82. doi: 10.1074/jbc.M109.049809. Epub 2009 Oct 6.
5
CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.原纤维Aβ刺激的小胶质细胞激活需要CD14以及Toll样受体2和4。
J Neurosci. 2009 Sep 23;29(38):11982-92. doi: 10.1523/JNEUROSCI.3158-09.2009.
6
MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection.在单核细胞增生李斯特菌感染期间,髓样分化因子88(MyD88)和I型干扰素受体介导趋化因子诱导及单核细胞募集。
J Immunol. 2009 Jul 15;183(2):1271-8. doi: 10.4049/jimmunol.0900460. Epub 2009 Jun 24.
7
Regulation of innate immune responses in the brain.大脑中固有免疫反应的调节
Nat Rev Immunol. 2009 Jun;9(6):429-39. doi: 10.1038/nri2565.
8
Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.老年APP23转基因小鼠淀粉样斑块相关脑组织中Toll样受体mRNA的差异调节
Neurosci Lett. 2009 Mar 27;453(1):41-4. doi: 10.1016/j.neulet.2009.01.075. Epub 2009 Feb 4.
9
Microglial physiology: unique stimuli, specialized responses.小胶质细胞生理学:独特的刺激,特殊的反应。
Annu Rev Immunol. 2009;27:119-45. doi: 10.1146/annurev.immunol.021908.132528.
10
Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology.诱导Toll样受体9信号传导作为改善阿尔茨海默病相关病理的一种方法。
J Neurosci. 2009 Feb 11;29(6):1846-54. doi: 10.1523/JNEUROSCI.5715-08.2009.